Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


BIO 2016 Notebook: Patient Perspectives, Risk-Sharing, Microbiomes and Incubating Success

Executive Summary

Scrip's second full day of meetings and events during the annual BIO International Convention delivered diverse insights about including patients in drug development, sharing risk with CROs, microbiome-targeting therapies, and the benefits of incubating early-stage technology.


Related Content

Green Shoots: Pharma Investments In Early Innovation Support Biotech Growth
Agony & Ecstasy Of Sarepta: A New FDA Rare Disease Standard?
VC Roundup: Caribou Completes $30m Non-IPO CRISPR Financing; $205m In Cash For Five Others
Biotech VC Funding Rises As Fewer Companies Get More Dollars
J&J Opens Houston Incubator With 21 Startups, 12 Biopharma Firms
J&J Starts The Year With A Bang: 22 Early-Stage Deals
BioNotebook: Juno's $134m Series B more than 3 VC deals combined
BioNotebook: Second Genome/Pfizer, Merck/Agenus, Endo/Somar, Parion/Gilead, Lightstone Ventures, Kite Pharma, five IPO updates
J&J enters deal with Second Genome to study gut bacteria
J&J forms 'innovation centres' in global biotech hubs to access emerging tech


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts